Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances

Table 2 Human immunodeficiency virus and hepatitis C virus seroprevalences, hepatitis C virus-RNA and genotype in the 2 series

Series	n	HIV Ab	HCV Ab	PCR-HCV	HCV genotype
		%	%	%	1	2	other
Series 1	1000	4.10	0.20	0.10	0	1	0
W ≤ 50 yr old
Series 2	231	6.06	6.49	5.60	2	10	0
W > 50 yr old

Series 1 (W ≤ 50 years old): Young women population; Series 2 (W > 50 years old): Older women; HIV Ab: Serological markers of human immunodeficiency virus (HIV) (or anti-HIV); HCV Ab: Serological markers of hepatitis C virus (HCV) (or anti-HCV); PCR HCV: Virological markers of HCV [polymerase chain reaction (PCR) reactive results, or RNA detection]; %: Prevalence.